4.2 Article

Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome

Journal

JOURNAL OF HUMAN NUTRITION AND DIETETICS
Volume 27, Issue -, Pages 263-275

Publisher

WILEY
DOI: 10.1111/jhn.12144

Keywords

hydrogen breath tests; intestinal absorption; irritable bowel syndrome; mannitol; polyols; sorbitol malabsorption

Ask authors/readers for more resources

BackgroundSorbitol and mannitol are naturally-occurring polyol isomers. Although poor absorption and induction of gastrointestinal symptoms by sorbitol are known, the properties of mannitol are poorly described. We aimed to expand data on food composition of these polyols, and to compare their absorptive capacities and symptom induction in patients with irritable bowel syndrome (IBS) and healthy individuals. MethodsFood samples were analysed for sorbitol and mannitol content. The degree of absorption measured by breath hydrogen production and gastrointestinal symptoms (visual analogue scales) was evaluated in a randomised, double-blinded, placebo-controlled study in 21 healthy and 20 IBS subjects after challenges with 10g of sorbitol, mannitol or glucose. ResultsCertain fruits and sugar-free gum contained sorbitol, whereas mannitol content was higher in certain vegetables. Similar proportions of patients with IBS (40%) and healthy subjects (33%) completely absorbed sorbitol, although more so with IBS absorbed mannitol (80% versus 43%; P=0.02). Breath hydrogen production was similar in both groups after lactulose but was reduced in patients with IBS after both polyols. No difference in mean (SEM) hydrogen production was found in healthy controls after sorbitol [area-under-the-curve: 2766(591)ppm4h(-1)] or mannitol [2062(468)ppm4h(-1)] but, in patients with IBS, this was greater after sorbitol [1136(204)ppm4h(-1)] than mannitol [404(154)ppm4h(-1); P=0.002]. Overall gastrointestinal symptoms increased significantly after both polyols in patients with IBS only, although they were independent of malabsorption of either of the polyols. ConclusionsIncreased and discordant absorption of mannitol and sorbitol occurs in patients with IBS compared to that in healthy controls. Polyols induced gastrointestinal symptoms in patients with IBS independently of their absorptive patterns, suggesting that the dietary restriction of polyols may be efficacious.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Gastroenterology & Hepatology

Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach

Ashish Srinivasan, Peter De Cruz, Daniel R. van Langenberg

Article Gastroenterology & Hepatology

Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas

Michael De Gregorio, Tanya Lee, Krupa Krishnaprasad, Gregory Amos, Yoon-Kyo An, Matthew Bastian-Jordan, Jakob Begun, Nira Borok, Dougal J. M. Brown, Wa Cheung, Susan J. Connor, Jan Gerstenmaier, Lauren E. Gilbert, Robert Gilmore, Bonita Gu, Numan Kutaiba, Allan Lee, Gillian Mahy, Ashish Srinivasan, Lena Thin, Alexander J. Thompson, Christopher J. Welman, Eric X. Z. Yong, Peter De Cruz, Daniel van Langenberg, Miles P. Sparrow, Nik S. Ding

Summary: The study examines the association between anti-TNF drug levels and radiologic outcomes in perianal fistulising Crohn's disease, and finds that higher drug levels are associated with improved radiologic results.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Editorial: delving into the natural history of Crohn's disease and the impact of medical therapy

Abhinav Vasudevan, Daniel R. van Langenberg

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Direct health care costs of managing perianal Crohn's Disease in a population based cohort

R. D. Hirsch, C. Keung, D. Con, A. Vasudevan, D. R. Van Langenberg, O. Niewiadomski

Summary: This study aimed to assess the cost of treating perianal Crohn's disease and compare it with non-perianal Crohn's disease patients. The results showed that while overall costs were similar, perianal patients had higher surgical costs, indicating the potential benefit of early intensive treatment to reduce future surgical costs.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2022)

Review Gastroenterology & Hepatology

Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn's disease

Ashish Srinivasan, Robert Gilmore, Daniel van Langenberg, Peter De Cruz

Summary: Anti-TNF dose intensification is clinically effective in patients with Crohn's disease, particularly within the first 6 months. However, a proportion of patients may fail to demonstrate short-term and/or sustained clinical response. Hence, clinical reassessment remains important, particularly beyond 6 months of dose intensification.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)- lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R. van Langenberg, Abhinav Vasudevan

Summary: In this study, CAR and CLR measured on day 3 post infliximab salvage for steroid-refractory ASUC were found to be strong predictors of colectomy, showing potential utility in predicting subsequent treatment outcomes. Prospective studies are needed to further confirm the predictive value of these biomarkers.

INTESTINAL RESEARCH (2022)

Article Oncology

The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease

Krishneel Dutt, Ashish Srinivasan, Daniel Van Langenberg

Summary: This study evaluated the nocebo effect in patients with inflammatory bowel disease (IBD) who switched from originator to biosimilar medicines. The study found a temporary nocebo effect in the first 16 weeks following non-medical switching, but it was not sustained at week 32. Overcoming negative patient perceptions can be achieved through a patient-inclusive approach to non-medical switching, along with close clinical follow-up and disease monitoring.

BIODRUGS (2022)

Article Gastroenterology & Hepatology

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

Alex Barnes, Soong-Yuan J. Ooi, Kate D. Lynch, Nina Parthasarathy, Maria Bishara, Michael Gounder, Rachel Grafton, Peta Leach, Peter Bampton, Alexandra Sechi, Watson Ng, Susan Connor, Daniel van Langenberg, Reme Mountifield, Jane M. Andrews

Summary: This study aimed to evaluate the long-term outcomes of patients on thiopurines following therapeutic drug monitoring (TDM) for the treatment of inflammatory bowel disease (IBD). The findings showed that TDM resulted in a change in management for the majority of patients and led to an increase in the number of patients in remission. Proactive TDM allowed for the identification and management of inappropriate dosing and was associated with higher levels of clinical remission.

DIGESTIVE DISEASES AND SCIENCES (2023)

Review Medicine, General & Internal

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease

Anuj Bohra, Abhinav Vasudevan, Numan Kutaiba, Daniel R. Van Langenberg

Summary: Magnetic resonance enterography (MRE) is a commonly used tool for assessing patients with small bowel Crohn's disease. This review examines the impact of image quality on the accuracy of small bowel CD activity assessment and discusses strategies to improve image quality in MRE.

DIAGNOSTICS (2022)

Article Gastroenterology & Hepatology

Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses

Ashish Srinivasan, Peter De Cruz, Melissa Sam, Catherine Toong, Daniel R. van Langenberg

Summary: This study compared two different strategies, repeat infliximab induction and shorter dose interval, for addressing secondary loss of response in patients with inflammatory bowel disease. The study found that both strategies had similar clinical response rates, but they resulted in distinct pharmacokinetic profiles.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study)

Abhinav Vasudevan, Danny Con, Peter De Cruz, Miles P. Sparrow, Antony B. Friedman, Mayur Garg, Soleiman Kashkooli, Peter R. Gibson, Daniel R. van Langenberg

Summary: This study compared the use of thiopurine-allopurinol combination therapy with standard thiopurine therapy in IBD. The results showed that the thiopurine-allopurinol group had better outcomes in the primary efficacy assessment, fewer adverse events, and less frequent thiopurine dose adjustments.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Utility of panenteric capsule endoscopy for the detection of small-bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study

Anuj Bohra, Diana Lewis, Jonathan P. Segal, Abhinav Vasudevan, Daniel R. Van Langenberg, Olga Niewiadomski

Summary: This study examines the diagnostic utility of panenteric Crohn's capsule endoscopy in detecting active small-bowel Crohn's disease when imaging is normal but there is a high clinical suspicion. The results show that Crohn's CE is an effective diagnostic test that can improve quality of life and guide treatment.

JGH OPEN (2023)

Review Gastroenterology & Hepatology

Intestinal Ultrasound in the Assessment of Luminal Crohn's Disease

Anuj Bohra, Daniel R. Van Langenberg, Abhinav Vasudevan

Summary: Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract. Intestinal ultrasound is a noninvasive and objective method for assessing disease activity, with advantages in diagnostic accuracy and disease monitoring, particularly during pregnancy and for fibrosis detection.

GASTROINTESTINAL DISORDERS (2022)

Meeting Abstract Gastroenterology & Hepatology

6-THIOGUANINE NUCLEOTIDE LEVELS AND ANTI-TNFa TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A RETROSPECTIVE MULTICENTRE STUDY

Natalie Yu, Daniel Tassone, Tanya Lee, Steven Phan, Damien M. Wu, Jason Zhang, Luke Wang, Jason Tjahyadi, Krishneel Dutt, Hana Liou, Chamara Basnayake, Emily K. Wright, Mark Lust, Ola Niewiadomski, Michael A. Kamm, William Connell, Alexander Thompson, Ida Hilmi, Raja Affendi Raja Ali, Shu Chen Wei, Peter De Cruz, Antony Friedman, Gregory T. Moore, Daniel R. Van Langenberg, Nik S. Ding

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

INFLIXIMAB DOSE INTENSIFICATION FOR SECONDARY LOSS OF RESPONSE IN IBD: UPFRONT INTENSIFICATION IS SIMILARLY EFFECTIVE TO DOSE INTERVAL SHORTENING WITH THE ADDED BENEFIT OF EARLY PREDICTORS OF RESPONSE

Ashish Srinivasan, Peter De Cruz, Melissa Sam, Catherine Toong, Daniel R. Van Langenberg

GASTROENTEROLOGY (2022)

No Data Available